157 related articles for article (PubMed ID: 1924009)
1. Hyperlipidemia. What to do when life-style changes aren't enough.
Peters WL
Postgrad Med; 1991 Oct; 90(5):213-7, 220-4. PubMed ID: 1924009
[TBL] [Abstract][Full Text] [Related]
2. Drug treatment of dyslipoproteinemia.
Larsen ML; Illingworth DR
Med Clin North Am; 1994 Jan; 78(1):225-45. PubMed ID: 8283933
[TBL] [Abstract][Full Text] [Related]
3. Currently available lipid-lowering agents.
Levy RI
Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():14-21. PubMed ID: 3134381
[No Abstract] [Full Text] [Related]
4. Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration.
Ulbricht C; Basch E; Szapary P; Hammerness P; Axentsev S; Boon H; Kroll D; Garraway L; Vora M; Woods J;
Complement Ther Med; 2005 Dec; 13(4):279-90. PubMed ID: 16338199
[TBL] [Abstract][Full Text] [Related]
5. Practical drug therapy for common hyperlipidaemias.
Tikkanen MJ
Baillieres Clin Endocrinol Metab; 1990 Dec; 4(4):719-42. PubMed ID: 2082904
[No Abstract] [Full Text] [Related]
6. Perspectives in the treatment of dyslipidemias in the prevention of coronary heart disease.
Borgia MC; Medici F
Angiology; 1998 May; 49(5):339-48. PubMed ID: 9591525
[TBL] [Abstract][Full Text] [Related]
7. Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome.
Vega GL; Ma PT; Cater NB; Filipchuk N; Meguro S; Garcia-Garcia AB; Grundy SM
Am J Cardiol; 2003 Apr; 91(8):956-60. PubMed ID: 12686335
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of simvastatin in patients with hypercholesterolemia (results of a Multicenter Clinical Study)].
Kukharchuk VV; Bubnova MG; Katel'nitskaia LI; Nikitin IuP; Ol'binskaia LI;
Kardiologiia; 2003; 43(5):42-7. PubMed ID: 12891239
[TBL] [Abstract][Full Text] [Related]
9. A comparative review of the adverse effects of treatments for hyperlipidaemia.
Steiner A; Weisser B; Vetter W
Drug Saf; 1991; 6(2):118-30. PubMed ID: 2043283
[TBL] [Abstract][Full Text] [Related]
10. Genetically defined hyperlipidemia.
Smit JW; Diamant M
Pharmacogenomics; 2004 Apr; 5(3):295-304. PubMed ID: 15102544
[TBL] [Abstract][Full Text] [Related]
11. [Lipid risk factors of atherosclerosis: who, when, how to treat?].
Foubert L; Dejager S; Bruckert E; Turpin G
Ann Endocrinol (Paris); 1997; 58(4):275-82. PubMed ID: 9436473
[TBL] [Abstract][Full Text] [Related]
12. [Anti-hyperlipidemic drug].
Nakaya N
Nihon Rinsho; 1999 Jul; 57(7):1570-6. PubMed ID: 10429459
[TBL] [Abstract][Full Text] [Related]
13. Strategies for minimizing hyperlipidemia after cardiac transplantation.
Kirklin JK; Benza RL; Rayburn BK; McGiffin DC
Am J Cardiovasc Drugs; 2002; 2(6):377-87. PubMed ID: 14727953
[TBL] [Abstract][Full Text] [Related]
14. [Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia].
Yeshurun D; Hamood H; Morad N; Naschitz J
Harefuah; 2000 Apr; 138(8):650-3, 710. PubMed ID: 10883206
[TBL] [Abstract][Full Text] [Related]
15. Management of protease inhibitor-associated hyperlipidemia.
Penzak SR; Chuck SK
Am J Cardiovasc Drugs; 2002; 2(2):91-106. PubMed ID: 14727985
[TBL] [Abstract][Full Text] [Related]
16. Perioperative Management of Hyperlipidemia Medications.
Renew JR
Curr Clin Pharmacol; 2017; 12(3):152-156. PubMed ID: 29119935
[TBL] [Abstract][Full Text] [Related]
17. [Optimization of cholesterol reduction principles and clinical results of dual inhibition].
von Hodenberg E
Internist (Berl); 2005 May; 46 Suppl 1():S18-23. PubMed ID: 15834540
[TBL] [Abstract][Full Text] [Related]
18. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.
Sawada T; Tsubata H; Hashimoto N; Takabe M; Miyata T; Aoki K; Yamashita S; Oishi S; Osue T; Yokoi K; Tsukishiro Y; Onishi T; Shimane A; Taniguchi Y; Yasaka Y; Ohara T; Kawai H; Yokoyama M
Cardiovasc Diabetol; 2016 Aug; 15(1):121. PubMed ID: 27565734
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of hyperlipidemia in pediatric heart transplant recipients: current practice and future directions.
Chin C; Bernstein D
Paediatr Drugs; 2005; 7(6):391-6. PubMed ID: 16356026
[TBL] [Abstract][Full Text] [Related]
20. 2017 Taiwan lipid guidelines for high risk patients.
Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
